ASTRAZENECA PLC (AZNCF)
Clinical trial NCT06471257 updates: 1. completion date: 2026-10-30 → 2027-10-04 2. primary completion date: 2026-10-30 → 2027-10-04 3. enrollment: 790 → 1000 participants
Clinical trial NCT06471257 updates: 1. completion date: 2026-10-30 → 2027-10-04 2. primary completion date: 2026-10-30 → 2027-10-04 3. enrollment: 790 → 1000 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical